Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Summary

Idiopathic osteoporosis (IOP) is an uncommon disorder in which otherwise healthy young individuals sustain one or more low-trauma fractures. Teriparatide \[PTH(1-34)\], which is FDA approved for treatment of osteoporosis in men and postmenopausal women, works by stimulating bone formation. The investigators hypothesize that teriparatide will significantly increase bone density (BMD) and improve bone structure in premenopausal women with IOP.

Timeline

Start

2008-08-20

Primary completion

2012-01-03

Completion

2012-01-03

Drugs

Indications